Otsuka America

DACOGEN

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / DACOGEN – J0894

Manufacturer:

Otsuka America

Name:

DACOGEN

HCPCS Code Descriptor:

Injection, decitabine, 1 mg

Category:

J Code

HCPCS:

J0894

NDC(s):

75834-0190-01, 72603-0107-01, 72205-0031-01, 72205-0036-01, 71288-0119-20, 70860-0219-20, 70121-1644-01, 69097-0905-67, 68001-0573-41, 67457-0316-25, 63323-0825-20, 59148-0046-70, 55150-0376-01, 55111-0556-10, 50742-0430-01, 43598-0427-37, 43598-0348-37, 25021-0231-20, 16729-0224-05, 00781-3139-80, 00143-9385-01

Primary Type:

Oncology

Generic Status:

Multi-Source

Route of Administration:

Intravenous

About:

DACOGEN is an Oncology drug manufactured by Otsuka America and administered via the Intravenous route of administration. The J Code: J0894 is aligned to the drug DACOGEN.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

1/1/07

HCPCS Effective Date:

1/1/23

HCPCS Short Description:

Decitabine injection

Billing and Coding Guide:

Not Found

Patient Assistance:

Not Found